Related Experiment Video
Updated: Dec 13, 2025
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.2K
It's time to rethink your approach to C diff infection
Kelsea Zukauckas1, Jeremy Vandiver2, Lauren Biehle1
1University of Wyoming School of Pharmacy, Laramie, USA.
The Journal of Family Practice
|July 30, 2020
Summary
Metronidazole is not the preferred initial treatment. Fecal microbiota transplantation is an effective option for specific patients needing alternative therapies.
Area of Science:
- Microbiology
- Gastroenterology
- Pharmacology
Background:
- Metronidazole was a common first-line therapy for certain conditions.
- Emerging evidence suggests limitations in metronidazole's efficacy.
- Alternative treatment strategies are being explored.
Purpose of the Study:
- To evaluate the current therapeutic landscape for specific conditions.
- To assess the effectiveness of fecal microbiota transplantation as an alternative to standard therapies.
- To determine if metronidazole remains the optimal first-line treatment.
Main Methods:
- Review of current clinical guidelines and treatment protocols.
- Analysis of clinical trial data comparing metronidazole with other interventions.
- Assessment of outcomes in patients undergoing fecal microbiota transplantation.
Main Results:
- Metronidazole is no longer considered the primary drug of choice for initial therapy.
- Fecal microbiota transplantation has demonstrated significant efficacy in select patient populations.
- Treatment guidelines are shifting towards alternative approaches.
Conclusions:
- Current evidence does not support metronidazole as the first-line treatment.
- Fecal microbiota transplantation represents a viable and effective therapeutic option for specific patient groups.
- Further research may refine the role of fecal microbiota transplantation in clinical practice.
Related Concept Videos
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
4.3K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
01:22Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
341
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
341
01:17Drugs for Treatment of Diarrhea-Predominant IBS
503
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
503
01:21Inflammatory Bowel Disease V: Surgical Management
338
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
338
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
851
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
851